What Is Translational Research?
How we go from the lab bench to a child’s bedside
Translational research refers to ‘bench-to-bedside’ research, which means translating findings from fundamental science research into everyday clinical practice to improve human health and well-being. Our focus is on translational research, making sure our discoveries are progressed into actual treatments for kids with cancer as quickly as possible. We seek to discover new treatments specifically designed for children, to develop safer and less toxic drugs and treatment protocols that will minimise side-effects and ultimately give children with cancer the best chance of a cure with the highest possible quality of life.
This approach is being applied through the Zero Childhood Cancer program to give all participating children the highest possible chance of survival and quality of life. The research results we obtain from each child’s unique cancer are being translated back into the clinic in the fastest and most effective way possible so they can directly inform treatment decisions. Zero Childhood Cancer brings together all major Australian clinical and research groups working in childhood cancer to form a translational research pipeline that brings research closer to patients than ever before.
“The data we will be gathering and using is exciting in two respects - we will have evidence-based treatment options in the present, and we will be building a powerful research repository for the future.”
Professor Glenn Marshall AM